<PAGE> 1
-----------------------------
OMB APPROVAL
-----------------------------
OMB Number 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response . . 14.90
-----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___________)*
UroQuest Medical Corporation
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.001
- -------------------------------------------------------------------------------
(Title of Class of Securities)
917285 10 8
----------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 9 Pages
<PAGE> 2
CUSIP NO. 917285 10 8 13G PAGE 2 OF 9 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Warburg, Pincus Investors, L.P.
I.R.S. I.D. No.: 13-3549187
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
---------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY 3,188,572
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
3,188,572
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,188,572
---------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
26.92%
---------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
PN
---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 3
CUSIP NO. 917285 10 8 13G PAGE 3 OF 9 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Warburg, Pincus & Co.
I.R.S. I.D. No.: 13-6358475
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of New York
---------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY 3,188,572
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
3,188,572
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,188,572
---------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
26.92%
---------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
PN
---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 4
CUSIP NO. 917285 10 8 13G PAGE 4 OF 9 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
E.M. Warburg, Pincus & Co., LLC
I.R.S. I.D. No.: 13-3536000
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of New York
---------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY 3,188,572
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
3,188,572
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,188,572
---------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
26.92%
---------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
OO(Limited Liability Company)
---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 5
ITEM 1.
(a) Name of Issuer: UroQuest Medical Corporation (the "Issuer")
(b) Address of Principal Executive
Offices: 265 East 100 South, Suite 220
Salt Lake City, Utah 84111
ITEM 2.
(a) Names of Persons Filing: This statement is filed by and on
behalf of (a) Warburg, Pincus Investors, L.P., a Delaware limited partnership
("WPI"); (b) Warburg, Pincus & Co., a New York general partnership ("WP"); and
(c) E.M. Warburg, Pincus & Co., LLC, a New York limited liability company ("EMW
LLC"), which manages WPI. WP, the sole general partner of WPI, has a 20%
interest in the profits of WPI. Lionel I. Pincus is the managing partner of WP
and the managing member of EMW LLC and may be deemed to control both WP and EMW
LLC. The members of EMW LLC are substantially the same as the partners of WP.
(b) Address of Principal Business Office: The business address of
each of the entities identified above in Item 2(a) is 466 Lexington Avenue, New
York, New York 10017.
(c) Citizenship: WPI is a limited partnership organized under the
laws of the State of Delaware. WP is a general partnership and EMW LLC is a
limited liability company, both of which are organized under the laws of the
State of New York.
(d) Title of Class of Securities: Common Stock, par value $0.001
of the Issuer.
(e) CUSIP Number: 917285 10 8
ITEM 3.
This statement is not filed pursuant to Rule 13d-1(b) or 13d-2(b).
ITEM 4. OWNERSHIP
As of December 31, 1996, WPI was the beneficial and record owner of
3,188,572 shares of the Issuer's Common Stock (the "Shares"), whereby WPI had
and currently has shared investment and shared voting power with respect to the
Shares by virtue of the control relationships described in Item 2 above. The
Shares constitute 26.92% of the outstanding shares of the Issuer's Common Stock
as of December 31, 1996.
Page 5 of 9 Pages
<PAGE> 6
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
Not applicable.
Page 6 of 9 Pages
<PAGE> 7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WARBURG, PINCUS INVESTORS, L.P.
BY: WARBURG, PINCUS & CO.
General Partner
/s/ STEPHEN DISTLER
-----------------------------------
By: Stephen Distler, Partner
WARBURG, PINCUS & CO.
/s/ STEPHEN DISTLER
-----------------------------------
By: Stephen Distler, Partner
E.M. WARBURG, PINCUS & CO., LLC
/s/ STEPHEN DISTLER
-----------------------------------
By: Stephen Distler, Member
Dated: February 12, 1997
<PAGE> 8
SCHEDULES
Schedule I Joint Filing Agreement, dated February 12, 1997, among the
signatories to this Schedule 13G.
Page 8 of 9 Pages
<PAGE> 9
JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(f)(1)
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13G is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13G shall be filed on
behalf of each of the undersigned without the necessity of filing additional
joint filing agreements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning it contained therein, but shall not
be responsible for the completeness and accuracy of the information concerning
the others, except to the extent that it knows or has reason to believe that
such information is inaccurate. This Agreement may be executed in any number
of counterparts and all of such counterparts taken together shall constitute
one and the same instrument.
Dated: February 12, 1997
WARBURG, PINCUS INVESTORS, L.P.
By: Warburg, Pincus & Co., General Partner
By: /s/ STEPHEN DISTLER
--------------------------------------
Stephen Distler, Partner
WARBURG, PINCUS & CO.
By: /s/ STEPHEN DISTLER
--------------------------------------
Stephen Distler, Partner
E.M. WARBURG, PINCUS & CO., LLC
By: /s/ STEPHEN DISTLER
--------------------------------------
Stephen Distler, Member
